Skip to main content
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1977 Apr;53(618):223–224. doi: 10.1136/pgmj.53.618.223

Symptomatic hyponatraemia associated with tolbutamide therapy.

B A Darlow
PMCID: PMC2496491  PMID: 870894

Abstract

A case of hyponatraemic coma occurring in a patient with diabetes mellitus treated with tolbutamide is described. Although chlorpropamide is known to cause water retention in some circumstances, this is a less well recognized complication of tolbutamide therapy.

Full text

PDF
223

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Fichman M. P., Brooker G. Deficient renal cyclic adenosine 3'-5' monophosphate production in nephrogenic diabetes insipidus. J Clin Endocrinol Metab. 1972 Jul;35(1):35–47. doi: 10.1210/jcem-35-1-35. [DOI] [PubMed] [Google Scholar]
  2. Hagen G. A., Frawley T. F. Hyponatremia due to sulfonylurea compounds. J Clin Endocrinol Metab. 1970 Nov;31(5):570–576. doi: 10.1210/jcem-31-5-570. [DOI] [PubMed] [Google Scholar]
  3. Miller M., Moses A. M. Mechanism of chlorpropamide action in diabetes insipidus. J Clin Endocrinol Metab. 1970 Apr;30(4):488–496. doi: 10.1210/jcem-30-4-488. [DOI] [PubMed] [Google Scholar]
  4. Moses A. M., Howanitz J., Miller M. Diuretic action of three sulfonylurea drugs. Ann Intern Med. 1973 Apr;78(4):541–544. doi: 10.7326/0003-4819-78-4-541. [DOI] [PubMed] [Google Scholar]
  5. Webster B., Bain J. Antidiuretic effect and complications of chlorpropamide therapy in diabetes insipidus. J Clin Endocrinol Metab. 1970 Feb;30(2):215–227. doi: 10.1210/jcem-30-2-215. [DOI] [PubMed] [Google Scholar]
  6. Weissman P. N., Shenkman L., Gregerman R. I. Chlorpropamide hyponatremia: drug-induced inappropriate antidiuretic-hormone activity. N Engl J Med. 1971 Jan 14;284(2):65–71. doi: 10.1056/NEJM197101142840202. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES